The pathophysiological roles of 4.1N have been further studied in non-small cell lung cancer; it has been found that low 4.1N expression activated JNK-c-Jun signaling to promote tumor occurrence and development (Wang et al., 2016). This evidence concerns the gene JUN and non-small cell lung carcinoma.